S&P・Nasdaq 本質的価値 お問い合わせ

PMV Pharmaceuticals, Inc. PMVP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+1176.6%

合計 50 件の最近のインサイダー取引記録が記録されています PMV Pharmaceuticals, Inc. (PMVP), 内訳は 26 件の買い および 19 件の売り. インサイダー買い総額は $5.6M インサイダー売り総額は $6.65M.

最近活動のある主要インサイダーには Mack David Henry, Ticktin Robert, Jalota Deepika. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.

インサイダー取引記録 — PMVP

日付 氏名 役職 取引種別 株数 平均価格 価値 保有株数
2026-03-05 Mack David Henry President and CEO RSU 付与(制限付株式) 744,960 $1.53 $1.14M 744,960
2026-03-05 Ticktin Robert General Counsel & COO RSU 付与(制限付株式) 319,270 $1.53 $488.48K 319,270
2026-03-05 Jalota Deepika Chief Development Officer RSU 付与(制限付株式) 303,310 $1.53 $464.06K 303,310
2026-03-05 Carulli Michael Chief Financial Officer RSU 付与(制限付株式) 240,000 $1.53 $367.2K 240,000
2025-10-27 Mack David Henry President and CEO オプション行使(売却) 220,643 $1.37 $302.28K -
2025-10-23 Orbimed Advisors Llc 10 Percent Owner 情報に基づく売り 1,000,000 $1.52 $1.52M 4,975,291
2025-09-10 Orbimed Advisors Llc 10 Percent Owner 情報に基づく売り 500,000 $1.80 $900K 5,975,291
2025-07-01 Mack David Henry President and CEO 情報に基づく売り 58,411 $1.06 $62.18K 536,133
2025-07-01 Ticktin Robert General Counsel & COO 情報に基づく売り 23,151 $1.06 $24.65K 98,695
2025-07-01 Jalota Deepika Chief Development Officer 情報に基づく売り 33,065 $1.06 $35.2K 89,959
2025-07-01 Carulli Michael Chief Financial Officer 情報に基づく売り 28,249 $1.06 $30.08K 60,146
2025-06-05 Levine Arnold J Director RSU 付与(制限付株式) 33,500 $0.95 $31.83K 33,500
2025-06-05 Gallagher Carol Giltner Director 贈与(送付) 33,500 $0.95 $31.83K -
2025-06-05 Baum Charles M Director RSU 付与(制限付株式) 33,500 $0.95 $31.83K 33,500
2025-06-05 Heyman Richard A. Director RSU 付与(制限付株式) 33,500 $0.95 $31.83K 33,500
2025-06-05 Stelzer Laurie Director RSU 付与(制限付株式) 33,500 $0.95 $31.83K 33,500
2025-06-05 Flowers Kirsten Director RSU 付与(制限付株式) 33,500 $0.95 $31.83K 33,500
2025-04-21 Ticktin Robert General Counsel & COO 不明 265,000 $1.32 $349.8K -
2025-03-03 Mack David Henry President and CEO RSU 付与(制限付株式) 800,000 $1.32 $1.06M 800,000
2025-03-03 Jalota Deepika Chief Development Officer RSU 付与(制限付株式) 300,000 $1.32 $396K 300,000
2025-03-03 Carulli Michael Chief Financial Officer RSU 付与(制限付株式) 265,000 $1.32 $349.8K 265,000
2025-01-03 Mack David Henry President and CEO オプション行使(売却) 17,709 $0.53 $9.39K -
2024-12-03 Mack David Henry President and CEO オプション行使(売却) 91,750 $0.53 $48.63K 17,709
2024-09-11 Jalota Deepika Chief Development Officer 情報に基づく売り 7,218 $1.50 $10.85K 118,283
2024-09-11 Carulli Michael Chief Financial Officer 情報に基づく売り 2,891 $1.50 $4.35K 88,395
2024-08-13 Mack David Henry President and CEO 株式返還 330,000 $5.70 $1.88M -
2024-08-13 Jalota Deepika Chief Development Officer 株式返還 22,674 $28.33 $642.35K -
2024-08-13 Carulli Michael Chief Financial Officer 株式返還 13,605 $28.33 $385.43K -
2024-06-07 Gallagher Carol Giltner Director 贈与(送付) 67,500 $1.65 $111.38K -
2024-06-06 Levine Arnold J Director RSU 付与(制限付株式) 67,500 $1.65 $111.38K 67,500
2024-06-06 Gallagher Carol Giltner Director RSU 付与(制限付株式) 67,500 $1.65 $111.38K 67,500
2024-06-06 Baum Charles M Director RSU 付与(制限付株式) 67,500 $1.65 $111.38K 67,500
2024-06-06 Heyman Richard A. Director RSU 付与(制限付株式) 67,500 $1.65 $111.38K 67,500
2024-06-06 Stelzer Laurie Director RSU 付与(制限付株式) 67,500 $1.65 $111.38K 67,500
2024-06-06 Flowers Kirsten Director RSU 付与(制限付株式) 67,500 $1.65 $111.38K 67,500
2024-01-18 Mack David Henry President and CEO RSU 付与(制限付株式) 163,890 - - 442,460
2024-01-18 Jalota Deepika Chief Development Officer RSU 付与(制限付株式) 95,555 - - 125,501
2024-01-18 Carulli Michael Chief Financial Officer RSU 付与(制限付株式) 82,220 - - 91,286
2024-01-05 Carulli Michael Chief Financial Officer 処分 75,000 $5.70 $427.5K -
2023-11-22 Orbimed Advisors Llc 10 Percent Owner 情報に基づく売り 87,786 $2.23 $195.76K -
2023-11-10 Mack David Henry President and CEO 贈与(受領) 85,307 - - 165,307
2023-10-18 Mack David Henry President and CEO オプション行使 198,407 $0.53 $105.16K 363,877
2023-09-15 Jalota Deepika Chief Development Officer 情報に基づく売り 4,104 $6.62 $27.17K 29,946
2023-09-15 Alland Leila Chief Medical Officer 情報に基づく売り 6,291 $6.62 $41.65K 45,909
2023-08-07 Mack David Henry President and CEO オプション行使 85,500 $0.53 $45.32K 165,470
2023-08-07 Mack David Henry President and CEO オプション行使(売却) 198,407 $0.53 $105.16K 109,459
2023-06-08 Levine Arnold J Director RSU 付与(制限付株式) 21,500 $5.59 $120.19K 21,500
2023-06-08 Gallagher Carol Giltner Director 贈与(送付) 21,500 $5.59 $120.19K -
2023-06-08 Baum Charles M Director RSU 付与(制限付株式) 21,500 $5.59 $120.19K 21,500
2023-06-08 Heyman Richard A. Director RSU 付与(制限付株式) 21,500 $5.59 $120.19K 21,500
情報付き — 公開市場取引(最も重要) 情報なし(買い) — 報酬・オプション行使・転換 情報なし(売り) — 源泉徴収・付与売却 中立 — 贈与・信託・失効
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る